GlaxoSmithKline's total assets for Q3 2025 were £82.58B, an increase of 1.69% from the previous quarter. GSK total liabilities were £61.37B for the fiscal quarter, a -0.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.